• 首頁
  • 投資者關系
  • 信息披露
  • 可持續發展
  • 廣藥動态
  • English
财務指标股本狀況流通股東 治理結構 股東回報情況公平在身邊投資者保護宣傳
定期報告臨時公告
可持續發展治理穩健:透明合規 行穩緻遠品質保障:匠心守護 健康可及價值創新:科技驅動 數智未來綠色發展:低碳循環 和諧共生合作共赢:共建生态 韌性發展可持續發展報告我們的故事
About UsFinancial HighlightsShare CapitalShareholdersDistribution PlanRegular ReportSustainabilityCSR & ESG Report
  • About Us
  • Financial Highlights
  • Share Capital
  • Shareholders
  • Distribution Plan
  • Regular Report
  • Sustainability
  • CSR & ESG Report

2025 Sustainability Report

2026-03-31 14:37:58

2024 Sustainability Report

2025-03-14 11:21:09

2023 Corporate Social Responsibility Report and ESG (Environmental, Social and Governance) Report

2024-03-16 11:21:17

2022 Corporate Social Responsibility Report and ESG (Environmental, Social and Governance) Report

2023-03-18 14:57:57

2021 Corporate social responsibility Report

2022-03-19 10:26:30

2020 Corporate social responsibility Report

2021-03-19 14:24:04

2019 Corporate social responsibility Report

2020-04-01 14:23:02

2018 Corporate social responsibility Report

2019-03-18 14:22:18

2017 Corporate social responsibility Report

2018-03-16 14:21:04

2016 CSR Report

2017-03-16 14:44:54

關於我們    |    聯系我們

電(diàn)話:(8620)66281011    傳(chuán)真:(8620)66281229    地址:廣州市荔灣區沙面北街45号

廣州白雲山醫藥集團股份有限公司 版權所有 Copyright © 2000-2020 gybys.com.cn, All Rights Reserved 粵ICP備13064121号